Structure–activity relationships of the N‐terminus of calcitonin gene‐related peptide: key roles of alanine‐5 and threonine‐6 in receptor activation
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background and Purpose: The N‐terminus of calcitonin gene‐related peptide (CGRP) is important for receptor activation, especially the disulphide‐bonded ring (residues 1–7). However, the roles of individual amino acids within this region have not been examined and so the molecular determinants of agonism are unknown. This study has examined the role of residues 1, 3–6 and 8–9, excluding C ys‐2 and C ys‐7. Experimental Approach: CGRP derivatives were substituted with either cysteine or alanine; further residues were introduced at position 6. Their affinity was measured by radioligand binding and their efficacy by measuring cAMP production in SK‐N‐MC cells and β‐arrestin 2 translocation in CHO‐K1 cells at the CGRP receptor. Key Results: Substitution of A la‐5 by cysteine reduced affinity 270‐fold and reduced efficacy for production of cAMP in SK‐N‐MCs. Potency at β‐arrestin translocation was reduced by ninefold. Substitution of T hr‐6 by cysteine destroyed all measurable efficacy of both cAMP and β‐arrestin responses; substitution with either alanine or serine impaired potency. Substitutions at positions 1, 4, 8 and 9 resulted in approximately 10‐fold reductions in potency at both responses. Similar observations were made at a second CGRP‐activated receptor, the AMY 1(a)receptor. Conclusions and Implications: A la‐5 and T hr‐6 are key determinants of agonist activity for CGRP.A la‐5 is also very important for receptor binding. Residues outside of the 1–7 ring also contribute to agonist activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 2×
“The CT receptor complexes with RAMPs to give the AMY1, AMY2 and AMY3 receptors for amylin (McLatchie et al., 1998; Christopoulos et al., 1999; Muff et al., 1999); these exist as either (a) or (b) forms depending on the splice variant of CT receptor that is involved (Poyner et al., 2002).”
BackgroundPoyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804 · cited 2×
“, 1999); these exist as either (a) or (b) forms depending on the splice variant of CT receptor that is involved (Poyner et al., 2002).”
BackgroundSelf-citationChristopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?
Barwell, J., Gingell, J. J., Watkins, H. A., Archbold, J. K., Poyner, D. R., & Hay, D. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01525.x · Cited by 80
Self-citationKatafuchi, T., Yasue, H., Osaki, T., & Minamino, N. (2009) · Peptides · doi:10.1016/j.peptides.2009.06.012 · Cited by 37 · cited 4×
“The CT receptor complexes with RAMPs to give the AMY1, AMY2 and AMY3 receptors for amylin (McLatchie et al., 1998; Christopoulos et al., 1999; Muff et al., 1999); these exist as either (a) or (b) forms depending on the splice variant of CT receptor that is involved (Poyner et al., 2002).”
BackgroundInfluentialThiebaud, D., Akatsu, T., Yamashita, T., Suda, T., Noda, T., Martin, R. E., Fletcher, A. E., & Prof. Martin, T. J. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650061016 · Cited by 36
Cited by
Amylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
Self-citationCGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Russo, A. F., & Hay, D. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00059.2021 · Cited by 382
Self-citationAllostery and biased agonism at class B G protein-coupled receptors
Wootten, D., Miller, L. J., Koole, C., Christopoulos, A., & Sexton, P. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00049 · Cited by 112
Bower, R. L., & Hay, D. L. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13496 · Cited by 104
Self-citation
Metadata
- Authors
- Hay, D. L., Harris, P. W. R., Kowalczyk, R., Brimble, M. A., Rathbone, D. L., Barwell, J., Conner, A. C., & Poyner, D. R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2013-12-23
- Volume
- 171
- Issue
- 2
- Pages
- 415-426
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1876645916
- Cited by
- 35
- References
- 6
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structure–activity relationships of the N‐terminus of calcitonin gene‐related peptide: key roles of alanine‐5 and threonine‐6 in receptor activation. https://app.cochat.ai/papers/10.1111/bph.12464
- The paper
- Hay, D. L., Harris, P. W. R., Kowalczyk, R., Brimble, M. A., Rathbone, D. L., Barwell, J., Conner, A. C., & Poyner, D. R. (2014). Structure–activity relationships of the N‐terminus of calcitonin gene‐related peptide: key roles of alanine‐5 and threonine‐6 in receptor activation. British Journal of Pharmacology. https://doi.org/10.1111/bph.12464
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.